Invenomic Capital Management’s Adeia ADEA Stock Holding History

Invenomic Capital Management’s Portfolio ADEA Stock Details ADEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,689,482	Closed	-$6.32M	–	141
2022 Q3	$6.32M	Sell	1,689,482 -289,786	-15%	-$1.19M	0.54%	62
2022 Q2	$7.56M	Buy	1,979,268 +9,741	+0.5%	+$40.8K	0.54%	58
2022 Q1	$7.44M	Buy	1,969,527 +1,489,596	+310%	+$6.78M	0.79%	38
2021 Q4	$2.4M	Buy	479,931 +85,250	+22%	+$425K	0.51%	61
2021 Q3	$1.97M	Buy	394,681 +140,846	+55%	+$759K	0.64%	53
2021 Q2	$1.49M	Buy	253,835 +68,834	+37%	+$391K	0.36%	59
2021 Q1	$1.06M	Sell	185,001 -283,375	-61%	-$1.63M	0.24%	75
2020 Q4	$2.59M	Buy	468,376 +179,920	+62%	+$780K	0.66%	28
2020 Q3	$877K	Sell	288,456 -73,354	-20%	-$271K	0.48%	68
2020 Q2	$1.41M	Buy	+361,810	New	+$1.37M	1.05%	37

Other funds holding ADEA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Harvey Partners Tarrytown, New York $1.46B AUM 78.13% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invenomic Capital Management's ADEA Position: Q4 2022 in Review

Invenomic Capital Management sold out of Adeia (ADEA) in Q4 2022, closing a stake of 1,689,482 shares — an estimated $6.32M sold.

Invenomic Capital Management first reported a position in ADEA in Q2 2020 and held it in 10 quarters. The position peaked at $7.56M in Q2 2022. 211 funds tracked by Wall St. Rank hold ADEA as of Q4 2022.

Invenomic Capital Management reported no remaining Adeia position as of Q4 2022 after selling out during the quarter.
Invenomic Capital Management sold 1,689,482 Adeia shares in Q4 2022, an estimated $6.32M.
Invenomic Capital Management first reported a position in Adeia in Q2 2020 and held it in 10 quarters.
Invenomic Capital Management's Adeia position peaked at $7.56M in Q2 2022.
211 funds tracked by Wall St. Rank held Adeia as of Q4 2022.

Based on Invenomic Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.